Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

ClinicalTrials.gov ID: NCT05056727

Public ClinicalTrials.gov record NCT05056727. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, International, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on CKD Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

Study identification

NCT ID
NCT05056727
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,112 participants

Conditions and interventions

Interventions

  • Sodium Zirconium Cyclosilicate (SZC) Drug
  • Placebo Drug
  • Lisinopril Drug
  • Valsartan Drug
  • Irbesartan Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 29, 2021
Primary completion
Feb 6, 2024
Completion
Feb 6, 2024
Last update posted
Jan 7, 2026

2021 – 2024

United States locations

U.S. sites
42
U.S. states
20
U.S. cities
39
Facility City State ZIP Site status
Research Site Surprise Arizona 85374
Research Site Tucson Arizona 85741
Research Site Canyon Country California 91351
Research Site Chula Vista California 91910
Research Site Northridge California 91324
Research Site San Dimas California 91773
Research Site South Gate California 90280
Research Site Tarzana California 91356
Research Site Denver Colorado 80230
Research Site Boynton Beach Florida 33435
Research Site Hialeah Florida 33012
Research Site Lauderdale Lakes Florida 33313
Research Site Ocoee Florida 34761
Research Site Temple Terrace Florida 33637
Research Site Nampa Idaho 83687
Research Site Chicago Illinois 60643
Research Site Oak Brook Illinois 60523
Research Site Fort Wayne Indiana 46804
Research Site Louisville Kentucky 40205
Research Site Boston Massachusetts 02114
Research Site Boston Massachusetts 02115
Research Site Flint Michigan 48532
Research Site Saint Clair Shores Michigan 48081
Research Site Columbia Missouri 65201
Research Site Kansas City Missouri 64111
Research Site Albuquerque New Mexico 87109
Research Site Albany New York 12205
Research Site Great Neck New York 11021
Research Site Winston-Salem North Carolina 27103
Research Site Cincinnati Ohio 45267
Research Site Bethlehem Pennsylvania 18017
Research Site Chester Pennsylvania 19013
Research Site Columbia South Carolina 29203
Research Site Orangeburg South Carolina 29118
Research Site Chattanooga Tennessee 37404
Research Site Arlington Texas 76015
Research Site Fort Worth Texas 76164
Research Site Houston Texas 77004
Research Site Houston Texas 77054
Research Site Houston Texas 77099
Research Site San Antonio Texas 78212
Research Site Newport News Virginia 23606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 234 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05056727, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 7, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05056727 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →